|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00385710 |
|
Date of registration:
|
10/10/2006 |
|
Primary sponsor: |
|
|
Public title:
|
Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy (Depakine)
|
|
Scientific title:
|
Randomized Placebo-controlled Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy |
|
Date of first enrolment:
|
November 2006 |
|
Target sample size:
|
28 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00385710 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Contacts
|
|
Name:
|
Pascal Derkinderen |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Centre Hospitalier Universitaire de Nantes |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients with possible or probable PSP
- from 45 to 75 year of age
Age minimum:
45 Years
Age maximum:
75 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Progressive Supranuclear Palsy
|
|
Intervention(s)
|
|
Drug: Placebo
|
|
Drug: valproic acid
|
|
Primary Outcome(s)
|
|
PSPRS score (specific score for PSP)
[Time Frame: This score will be measured every three months during the two-year follow up of the study]
|
|
Secondary Outcome(s)
|
|
Neuropsychological evaluation
[Time Frame: inclusion, one year and two years follow up]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|